Sudeep Pharma Limited
SBI Mutual Fund increased its stake in Sudeep Pharma Limited from 1.20% to 2.85%, purchasing 18,55,590 shares. Based on the current share price of ₹1050.30, the additional acquisition is valued at approximately ₹194.89 Cr.
A pharmaceutical excipient manufacturer established in 1989, Sudeep Pharma produces high-quality ingredients for medications, food-grade minerals, and specialty nutrition products. The company serves pharmaceutical, nutritional, and food industries across more than 100 countries worldwide. Its vertically integrated operations focus on delivering consistent quality, reliability, and technical support to global pharmaceutical and nutrition clients.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.